Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Sponsor: Wei Zhao
Summary
The investigators' purpose was to assess the feasibility of dosage individualization of the commonly used antineoplastic drugs and anti-infective drugs in children with hematoplastic disease.
Key Details
Gender
All
Age Range
1 Day - 18 Years
Study Type
INTERVENTIONAL
Enrollment
1500
Start Date
2016-01-31
Completion Date
2026-12-31
Last Updated
2025-03-30
Healthy Volunteers
No
Conditions
Interventions
Bortezomib
bortezomib was administered follow the doctor's advice.
Eltrombopag
eltrombopag was administered follow the doctor's advice.
Imatinib
imatinib was administered follow the doctor's advice.
dasatinib
dasatinib was administered follow the doctor's advice.
Pegaspargase
pegaspargase was administered follow the doctor's advice.
Anti-Infective Drugs
anti-infective drugs was administered follow the doctor's advice.
PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor
pegaspargase was administered follow the doctor's advice.
Locations (2)
Department of Pediatrics, the Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
State Key Laboratory of Experimental Haematology, Department of Paediatric Haematology, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Tanjin, Tianjin Municipality, China